Zacks7d agobearish
OCGN Falls on Wider Q1 Loss Despite Strong Pipeline Progress OutlookOcugen swings to a wider Q1 loss as costs climb, but pipeline milestones and gene therapy data keep its long-term plans on track.
News
High-signal headlines only — macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
310last 24h
1814last 7d
322🟢 bullish (7d)
187🔴 bearish (7d)
129publishers